Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guidelines – Lung and Thymic Carcinoids

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Published in 2021 – Ann Oncol (2021)
Authors: E Baudin, M Caplin, R Garcia-Carbonero, N Fazio, P Ferolla, PL Filosso, A Frilling, WW de Herder, D Hörsch, U Knigge, CM Korse, E. Lim, C Lombard-Bohas, M Pavel, JY Scoazec, A Sundin & A Berruti, on behalf of the ESMO Guidelines Committee

  • This updated ESMO Clinical Practice Guideline provides key recommendations on the management of lung and thymic carcinoids
  • Characterisation is best standardised in multidisciplinary expert centres
  • Prognosis guides the therapeutic management process
  • Dedicated lung carcinoids and thymic carcinoids trials are urgently needed

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings